HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Colleen Kelley, MD, MPH
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH

June 20th 2025

The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.

Image credit: Yale School of Medicine
Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

June 19th 2025

FDA Approved
Twice-Yearly Lenacapavir Approval Marks Major Milestone in Prevention of HIV

June 18th 2025

Zandraetta Tims-Cook
Contributor: PrEP in Practice – How to Start Conversations About HIV Prevention

June 17th 2025

Vaccine | Image credit: weyo - stock.adobe.com
Cuts to HIV Vaccine Research Come Amid Challenges to Other Vaccines, Treatment

June 13th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
June 21st 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases
June 21st 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 21st 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

This Week in Managed Care: March 2, 2018
March 2nd 2018

This Week in Managed Care: March 2, 2018

This week, the top managed care stories included a bipartisan group of governors releasing an outline for health reform; a report finds value-based contracts brings down prescription drug co-pays; 20 states file a lawsuit over the constitutionality of the Affordable Care Act.
Site Logo
March 1st 2018

Study Summary: EMERALD

NCCN Releases Guidelines to Address Treatment Gaps for People With HIV and Cancer
February 28th 2018

NCCN Releases Guidelines to Address Treatment Gaps for People With HIV and Cancer

Jaime Rosenberg
The National Comprehensive Cancer Center (NCCN) has released new NCCN Clinical Practice Guidelines in Oncology to help ensure that people living with HIV who are diagnosed with cancer receive safe and necessary treatment.
FDA Tentatively Approves Once-Daily, Fixed-Dose Combination HIV Treatment
February 22nd 2018

FDA Tentatively Approves Once-Daily, Fixed-Dose Combination HIV Treatment

Jaime Rosenberg
The FDA has tentatively approved Mylan’s New Drug Application for Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50mg/200mg/25mg, for the treatment of HIV/AIDS, and the drug will be immediately available in developing countries as a first-line regimen.
Telephone-Administered Therapy Reduces Depression in Patients With HIV
February 16th 2018

Telephone-Administered Therapy Reduces Depression in Patients With HIV

Jaime Rosenberg
A 9-week, telephone-administered interpersonal psychotherapy intervention reduced depression in patients living with HIV in rural areas, accrding to a study published in Annals of Behavioral Medicine.
CD4 Cell Counts Increased, Severe Immunodeficiency Decreased From 2002-2015
February 8th 2018

CD4 Cell Counts Increased, Severe Immunodeficiency Decreased From 2002-2015

Jaime Rosenberg
From 2002 to 2015, CD4 cell counts at the start of combination antiretroviral therapy (cART) increased, and the proportion of individuals with severe immunodeficiency at the start of cART decreased among all income groups, according to a study published in Clinical Infectious Diseases.
Researchers Develop Slow-Release Pill to Increase HIV Treatment Adherence
February 2nd 2018

Researchers Develop Slow-Release Pill to Increase HIV Treatment Adherence

Jaime Rosenberg
Using an “ingestible mini pill box,” researchers have developed a slow-release pill to deliver HIV treatment. Once inside the stomach, the capsule unfolds into a 6-armed structure, accommodating multiple drugs at a time.
"Unlikely to Have Been Exposed to HIV" Most Common Reason for Not Getting Tested
January 27th 2018

"Unlikely to Have Been Exposed to HIV" Most Common Reason for Not Getting Tested

Jaime Rosenberg
The most common reasons pepole give for never being tested for HIV is that they were "unlikely to have been exposed to HIV" and they were “never offered an HIV test," according to a National Health Statistics Reports.
NIH Launches Study to Compare 3 HIV Treatments in Pregnant Women
January 24th 2018

NIH Launches Study to Compare 3 HIV Treatments in Pregnant Women

Jaime Rosenberg
The study will evaluate the current preferred first-line regimen for pregnant women recommended by the World Health Organization and 2 regimens containing newer antiretroviral drugs that are becoming more widely used.
Researchers Develop More Accurate Tool to Identify New HIV Infections
January 17th 2018

Researchers Develop More Accurate Tool to Identify New HIV Infections

Jaime Rosenberg
Researchers at the Duke Human Vaccine Institute have developed a method that more accurately identifies new versus long-standing HIV infections, an important distinction when determining where to target public health initiatives and research.
More Than One-Third of Patients With HIV Did Not Receive HBV Vaccination
January 14th 2018

More Than One-Third of Patients With HIV Did Not Receive HBV Vaccination

Jaime Rosenberg
Although people with HIV are more susceptible to the hepatitis B virus, there is a low prevalence of hepatitis B vaccination among patients receiving medical care for HIV infection in the United States, according to a study in Annals of Internal Medicine.
Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds
January 12th 2018

Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds

Mary Caffrey
The same mechanisms that cause those with long-term HIV infection to suffer higher rates of heart attacks or strokes put children born with disease at early risk of cardiovascular disease, according to a new study.
Gates Discusses the Hope of Using Immuno-Oncology for HIV Breakthroughs, and More
January 9th 2018

Gates Discusses the Hope of Using Immuno-Oncology for HIV Breakthroughs, and More

Laura Joszt, MA
While public funding through the National Institutes of Health has created a foundation for healthcare research, the private sector can benefit from getting more involved, said Bill Gates, philanthropist and co-founder of Microsoft.
Age 25 is Optimal for Screening Adolescents, Young Adults Without Identified Risk Factors for HIV
January 7th 2018

Age 25 is Optimal for Screening Adolescents, Young Adults Without Identified Risk Factors for HIV

Jaime Rosenberg
Although an additional one-time screening at any age between 15 and 30 yields important gains in HIV diagnosis rates and life expectancy for HIV-infected people, screening at age 25 would provide the most favorable clinical outcomes and the best value for money, according to a study in the Journal of Adolescent Health.
Trump Administration Dismisses Members of HIV/AIDS Council as Nominations for New Council Near Deadline
January 2nd 2018

Trump Administration Dismisses Members of HIV/AIDS Council as Nominations for New Council Near Deadline

Jaime Rosenberg
The Trump administration dismissed the remaining members of the Presidential Advisory Council on HIV/AIDS as it prepares to appoint members to the 2018 council.
Dr Thomas C. Quinn Identifies Barriers to Preventing Spread of HIV
January 1st 2018

Dr Thomas C. Quinn Identifies Barriers to Preventing Spread of HIV

The biggest barriers to stopping the transmission of HIV are both the large population of infected people not receiving treatment and the lack of pre-exposure prophylaxis for high-risk individuals, said Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health.
Navigating Through Barriers in HIV Management
December 27th 2017

Navigating Through Barriers in HIV Management

Therapies in the Pipeline for HIV
December 27th 2017

Therapies in the Pipeline for HIV

Rapid Initiation of Antiretroviral Therapy
December 27th 2017

Rapid Initiation of Antiretroviral Therapy

Initiating and Managing Patients on PrEP
December 27th 2017

Initiating and Managing Patients on PrEP

Tighter Management of Patients With HIV
December 27th 2017

Tighter Management of Patients With HIV

Single-Tablet Regimens for Treating HIV
December 27th 2017

Single-Tablet Regimens for Treating HIV

The EMERALD and AMBER Trials in HIV
December 27th 2017

The EMERALD and AMBER Trials in HIV

Selecting a Therapeutic Regimen for HIV Treatment
December 27th 2017

Selecting a Therapeutic Regimen for HIV Treatment

Considerations for Prescribing Therapy for HIV
December 27th 2017

Considerations for Prescribing Therapy for HIV

A Current Look at Managing HIV
December 27th 2017

A Current Look at Managing HIV

Determining Cost-Effectiveness of Newer HIV Therapies
December 27th 2017

Determining Cost-Effectiveness of Newer HIV Therapies

Emerging Therapies in HIV
December 27th 2017

Emerging Therapies in HIV

Collaborative Approach in Managing HIV Treatment Costs
December 27th 2017

Collaborative Approach in Managing HIV Treatment Costs

HIV Therapy Utilization Management Concerns
December 27th 2017

HIV Therapy Utilization Management Concerns

<1
...
242526272829303132>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo